216 related articles for article (PubMed ID: 9838557)
1. Safety and effectiveness of microemulsion cyclosporine in renal allograft recipients: 1-year follow-up study.
Park K; Kim MS; Kim SI; Kim YS; Moon JI
Transplant Proc; 1998 Nov; 30(7):3556-7. PubMed ID: 9838557
[No Abstract] [Full Text] [Related]
2. Use of microemulsion form cyclosporine immediately after kidney transplantation without intravenous cyclosporine.
Jirasiritham S; Sumethkul V; Mavichak V; Jirasiritham S
Transplant Proc; 1998 Aug; 30(5):1760-1. PubMed ID: 9723270
[No Abstract] [Full Text] [Related]
3. Long-term results of conversion from existing to microemulsion formulation of cyclosporine.
Neumayer HH; Färber L; Budde K; Kohnen R; Maibücher A; Schuster A; Vollmar J; Waiser J; Luft FC
Transplant Proc; 1996 Aug; 28(4):2207-13. PubMed ID: 8769202
[No Abstract] [Full Text] [Related]
4. Cyclosporine: the principal immunosuppressant for renal transplantation.
Keown PA; Primmett DR
Transplant Proc; 1998 Aug; 30(5):1712-5. PubMed ID: 9723252
[No Abstract] [Full Text] [Related]
5. Conversion at first rejection: a prospective trial comparing cyclosporine microemulsion with tacrolimus in renal transplant recipients.
Dudley CR;
Transplant Proc; 2001; 33(1-2):1034-5. PubMed ID: 11267179
[No Abstract] [Full Text] [Related]
6. A one-year comparative study of Neoral vs Consupren in de novo renal transplant patients.
Stephan A; Masri MA; Barbari A; Aoun S; Rizk S; Kamel G
Transplant Proc; 1998 Nov; 30(7):3533-4. PubMed ID: 9838547
[No Abstract] [Full Text] [Related]
7. Excessive cyclosporine trough level variation with classic cyclosporine can be reduced with the new oral microemulsion formulation of cyclosporine.
Bökenkamp A; Offner G; Hoyer PF; Wonigeit K; Brodehl J
Transplant Proc; 1996 Aug; 28(4):2273-5. PubMed ID: 8769223
[No Abstract] [Full Text] [Related]
8. Neoral versus Sandimmune in kidney transplantation.
Tisone G; Orlando G; Mercadante E; Vennarecci G; Pisani F; Buonomo O; Negrini S; Casciani CU
Transplant Proc; 1998 Aug; 30(5):1749-50. PubMed ID: 9723265
[No Abstract] [Full Text] [Related]
9. Improvement of correlation between oral dose of cyclosporine and cyclosporinemia after substitution of cyclosporine standard presentation by cyclosporine microemulsion one, in 1345 patients with kidney transplantation. Spanish Sandimmune Neoral Conversion Group.
Gentil Govantes MA; Gómez Ullate P; Errasti P; Fernández Fresnedo G; Capdevila L; Sanz Guajardo A; Cubero JJ
Transplant Proc; 1998 Aug; 30(5):1658-9. PubMed ID: 9723231
[No Abstract] [Full Text] [Related]
10. A large, multicentre trial to compare the efficacy and safety of tacrolimus with cyclosporine microemulsion following renal transplantation.
Sperschneider H;
Transplant Proc; 2001; 33(1-2):1279-81. PubMed ID: 11267291
[No Abstract] [Full Text] [Related]
11. Long-term experience with Sandimmun Neoral: results in de novo and stable renal transplant patients after 24-month treatment. The German Neoral Study Group.
Korn A; Färber L; Maibücher A; Buchholz B; Offermann G
Transplant Proc; 1997 Nov; 29(7):2945-7. PubMed ID: 9365623
[No Abstract] [Full Text] [Related]
12. Microemulsion cyclosporine postmarketing surveillance in renal transplant recipients: multicenter study in Korea.
Korean Neoral Study Group
Transplant Proc; 2000 Nov; 32(7):1473-6. PubMed ID: 11119794
[No Abstract] [Full Text] [Related]
13. Cyclosporin Neoral and long-term survival of renal grafts.
Shaheen FA; Sheikh IA; al-Khader A
Transplant Proc; 1998 Nov; 30(7):3549. PubMed ID: 9838553
[No Abstract] [Full Text] [Related]
14. Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion.
Thervet E; Pfeffer P; Scolari MP; Toselli L; Pallardó LM; Chadban S; Pilmore H; Connolly J; Buchler M; Schena FP; Carreño CA; Dandavino R; Cole E
Transplantation; 2003 Sep; 76(6):903-8. PubMed ID: 14508352
[TBL] [Abstract][Full Text] [Related]
15. Neoral reduces the incidence of acute rejection after renal transplantation.
Sandrini S; Setti G; Gaggia P; Chiappini R; Maffeis R; Tardanico R; Maiorca R
Transplant Proc; 1998 Aug; 30(5):1758-9. PubMed ID: 9723269
[No Abstract] [Full Text] [Related]
16. Low incidence of rejection after synchronous pancreas-kidney transplantation with Neoral.
Cattral MS; Hemming AW; Greig PD; Rowsell C; Chari R; Wright E; Donat D; Cole E; Levy GA
Transplant Proc; 1998 Aug; 30(5):1946. PubMed ID: 9723346
[No Abstract] [Full Text] [Related]
17. Cyclosporine from twice to single daily dosing: impact on renal function, mortality, and graft loss.
Bianco PD; Silva HT; Boni R; Machado PG; Pacheco-Silva A; Pestana JO
Transplant Proc; 2002 Nov; 34(7):2920-1. PubMed ID: 12431657
[No Abstract] [Full Text] [Related]
18. Withdrawal versus continuous cyclosporine therapy in kidney transplant recipients of one-haplotype-matched donors.
Chew-Wong A; Alberú J; Abasta-Jiménez M; Alvarez-Sandoval E; Gabilondo-Navarro F; Correa-Rotter R
Transplant Proc; 1999; 31(1-2):1106-9. PubMed ID: 10083494
[No Abstract] [Full Text] [Related]
19. Renal recipients of haploidentical living donors treated with Neoral or conventional cyclosporine: a comparative follow-up of 3 years.
Gracida C; Melchor JL
Transplant Proc; 1998 Aug; 30(5):1742-3. PubMed ID: 9723262
[No Abstract] [Full Text] [Related]
20. Pharmacokinetics of cyclosporine microemulsion in Pakistani renal allograft recipients: correlation of trough peak levels with 7-point and 3-point AUC.
Hussain M; Zafar N; Bux A; Sultan S; Hashmi A; Hussain Z; Hafiz S; Naqvi A; Rizvi A
Transplant Proc; 1998 Nov; 30(7):3555. PubMed ID: 9838556
[No Abstract] [Full Text] [Related]
[Next] [New Search]
